Reducing inequalities through greater diversity in clinical trials – As important for medical devices as for drugs and therapeutics

In medicine and public health, the randomised controlled trial (RCT) is generally considered the key generator of ‘gold standard’ evidence. However, basic and clinical research and trials are often unrepresentative of real-world populations. Recruiting insufficiently diverse cohorts of participants...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Laurence S.J. Roope, Jessica Walsh, Maddie Welland, Gabrielle Samuel, Heidi Johansen-Berg, Anna C. Nobre, Stuart Clare, Helen Higham, Jon Campbell, Tim Denison, Karla L. Miller, Seena Fazel, Matthew L. Costa, Andrew Farmer, Marian Knight, Rachel Taylor, Lorna R. Henderson, Angeli Vaid, John Geddes, Vasiliki Kiparoglou, Helen McShane, Philip M. Clarke
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Elsevier 2025-06-01
Цуврал:	Contemporary Clinical Trials Communications
Нөхцлүүд:	Diversity Efficient trial design Inequality Levelling up Trial recruitment Underserved
Онлайн хандалт:	http://www.sciencedirect.com/science/article/pii/S2451865425000419
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!